secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2025-01-29T23:59:59+00:00
Accession:  0001493152-25-004143
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic receives Nasdaq delisting notice for failing to regain $1 bid price compliance
--------------------------------------------------------------------------------

- Nasdaq notified on Jan 22, 2025 that company failed to regain compliance with minimum bid price Rule 5550(a)(2).
- Company not eligible for second 180-day compliance period due to not meeting initial listing requirements.
- Company will present to Nasdaq Hearings Panel on Jan 30, 2025; no immediate delisting effect.
- Deficiency originally reported on July 24, 2024; stock closed below $1 for 30 consecutive business days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315225004143/0001493152-25-004143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315225004143/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-004143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer